A Win For Conatus Pharmaceuticals Inc.
Tue, May 05, 2020 at 05:30 PM
Conatus Pharmaceuticals Inc. (CNAT:NASDAQ) soared at $0.47, a gain of 38.3%. The stock appeared on our News Catalysts scanner on Sat 02 May 20 at 04:55 AM in the 'EARNINGS' category. From Mon 20 Apr 20, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Mon 20 Apr 20 at $0.43 with a volume of 3M+, and its share price has been moving sideways in recent weeks.
About Conatus Pharmaceuticals Inc. (CNAT:NASDAQ)
Conatus Pharmaceuticals Inc is a biotechnology company. It focuses on the development and commercialization of novel medicines to treat liver disease.
Top 10 Gainers:
- Portola Pharmaceuticals, Inc. (PTLA:NASDAQ), 130.03%
- Ritter Pharmaceuticals, Inc. (RTTR:NASDAQ), 87.68%
- Genprex, Inc. (GNPX:NASDAQ), 51.52%
- DropCar, Inc. (DCAR:NASDAQ), 49.08%
- BioPharmX Corporation (BPMX:NYSEMKT), 39.43%
- Staffing 360 Solutions, Inc. (STAF:NASDAQ), 38.89%
- Adverum Biotechnologies, Inc. (ADVM:NASDAQ), 38.35%
- Conatus Pharmaceuticals Inc. (CNAT:NASDAQ), 38.27%
- Akebia Therapeutics, Inc. (AKBA:NASDAQ), 37.99%
- Lightbridge Corporation (LTBR:NASDAQ), 37.78%